CIK: 0001389933 · Show all filings
Period: Q2 2013 (Next →)
Filing Date: Aug 14, 2013
Total Value ($000): $68,326 (92.8% shares, 7.2% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | PHARMACYCLICS INC | 102,128 | $8,116 | 11.9% | $79.47 | — | COM | 716933106 |
| — | NOVADAQ TECHNOLOGIES INC | 461,362 | $6,210 | 9.1% | $13.46 | — | COM | 66987G102 |
| ATRC | ATRICURE INC | 477,701 | $4,538 | 6.6% | $8.71 | 0.0% | COM | 04963C209 |
| — | PROTALIX BIOTHERAPEUTICS INC | 868,106 | $4,262 | 6.2% | $4.91 | — | COM | 74365A101 |
| PODD | INSULET CORP | 124,981 | $3,926 | 5.7% | $28.33 | 0.0% | COM | 45784P101 |
| — | INSULET CORP | 3,000,000 | $3,911 | 5.7% | $1.30 | — | NOTE 3.750% 6/1 | 45784PAC5 |
| — | NXSTAGE MEDICAL INC | 251,654 | $3,594 | 5.3% | $14.28 | — | COM | 67072V103 |
| — | ARIAD PHARMACEUTICALS INC | 191,215 | $3,344 | 4.9% | $17.49 | — | COM | 04033A100 |
| — | DISCOVERY LABORATORIES INC | 1,733,660 | $2,635 | 3.9% | $1.52 | — | COM NEW | 254668403 |
| — | CARDIONET INC | 401,788 | $2,371 | 3.5% | $5.90 | — | COM | 14159L103 |
| — | GIVEN IMAGING LTD | 156,320 | $2,190 | 3.2% | $14.01 | — | ORD SHS | M52020100 |
| — | DYAX CORP | 578,381 | $2,001 | 2.9% | $3.46 | — | COM | 26746E103 |
| — | CURIS INC | 549,896 | $1,754 | 2.6% | $3.19 | — | COM | 231269101 |
| — | INSPIREMD INC | 715,200 | $1,581 | 2.3% | $2.21 | — | COM NEW | 45779A309 |
| — | CARDICA INC | 1,063,469 | $1,180 | 1.7% | $1.11 | — | COM | 14141R101 |
| — | ACHILLION PHARMACEUTICALS | 121,800 | $996 | 1.5% | $8.18 | — | COM | 00448Q201 |
| — | NUVASIVE INC | 1,000,000 | $986 | 1.4% | $0.99 | — | NOTE 2.750% 7/0 | 670704AC9 |
| — | SPECTRANETICS CORP | 52,362 | $978 | 1.4% | $18.68 | — | COM | 84760C107 |
| — | XENOPORT INC | 191,262 | $947 | 1.4% | $4.95 | — | COM | 98411C100 |
| — | VENAXIS INC | 697,000 | $836 | 1.2% | $1.20 | — | COM | 92262A107 |
| JNJ | JOHNSON AND JOHNSON | 9,400 | $807 | 1.2% | $59.66 | 0.0% | COM | 478160104 |
| — | BAXANO SURGICAL INC | 336,351 | $807 | 1.2% | $2.40 | — | COM | 071773105 |
| — | BIOSPECIFICS TECHNOLOGIES | 51,692 | $806 | 1.2% | $15.59 | — | COM | 090931106 |
| — | SYNERON MEDICAL LTD | 90,947 | $791 | 1.2% | $8.70 | — | ORD SHS | M87245102 |
| — | CUTERA INC | 88,694 | $781 | 1.1% | $8.81 | — | COM | 232109108 |
| — | DERMA SCIENCES INC | 57,009 | $761 | 1.1% | $13.35 | — | COM PAR $.01 | 249827502 |
| INFU | INFUSYSTEM HOLDINGS INC | 474,484 | $707 | 1.0% | $1.53 | 0.0% | COM | 45685K102 |
| VRTX | VERTEX PHARMACEUTICALS INC | 8,600 | $689 | 1.0% | $73.64 | 0.0% | COM | 92532F100 |
| — | EXACTECH INC | 33,636 | $664 | 1.0% | $19.74 | — | COM | 30064E109 |
| — | RTI BIOLOGICS INC | 167,058 | $628 | 0.9% | $3.76 | — | COM | 74975N105 |
| — | UROPLASTY INC | 289,332 | $599 | 0.9% | $2.07 | — | COM NEW | 917277204 |
| — | ANACOR PHARMACEUTICALS INC | 106,993 | $598 | 0.9% | $5.59 | — | COM | 032420101 |
| — | KERYX BIOPHARMACEUTICALS | 77,000 | $575 | 0.8% | $7.47 | — | COM | 492515101 |
| — | KALOBIOS PHARMACEUTICALS INC | 79,834 | $452 | 0.7% | $5.66 | — | COM | 48344T100 |
| — | INTERCEPT PHARMACEUTICALS IN | 10,000 | $448 | 0.7% | $44.80 | — | COM | 45845P108 |
| MASI | MASIMO CORPORATION | 17,500 | $371 | 0.5% | $21.04 | 0.0% | COM | 574795100 |
| STXS | STEREOTAXIS INC | 221,508 | $343 | 0.5% | $1.58 | 0.0% | COM NEW | 85916J409 |
| — | THERAGENICS CORP | 160,719 | $333 | 0.5% | $2.07 | — | COM | 883375107 |
| — | PALATIN TECHNOLOGIES INC | 514,768 | $319 | 0.5% | $0.62 | — | COM PAR $.01 | 696077403 |
| — | GRAYMARK HEALTHCARE INC | 693,027 | $146 | 0.2% | $0.21 | — | COM | 389465303 |
| — | CYCLACEL PHARMACEUTICALS INC | 44,300 | $131 | 0.2% | $2.96 | — | COM NEW | 23254L306 |
| — | AUTHENTIDATE HOLDING CORP | 142,062 | $124 | 0.2% | $0.87 | — | COM NEW | 052666203 |
| — | DIGIRAD CORP | 36,672 | $89 | 0.1% | $2.43 | — | COM | 253827109 |
| — | COMBIMATRIX CORP | 2,325 | $1 | 0.0% | $0.43 | — | *W EXP 05/01/201 | 20009T121 |